UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-03-08 Future report Set alerts
Q3 2020 2020-11-10 Future report Set alerts
Q2 2020 2020-08-06 -0.03 -0.03
Q1 2020 2020-05-07 0.01 0.01
Q4 2019 2020-03-10 0.20 0.20
Q3 2019 2019-11-12 -0.02 -0.02
Q2 2019 2019-08-08 -0.03 -0.03
Q1 2019 2019-05-09 -0.05 -0.05
Q4 2018 2019-03-12 -0.01 0.03
Q3 2018 2018-11-07 -0.05 -0.05

Ratings

2016-03-14 Boost Price Target Jefferies Group Hold $4.00 to $6.00
2016-01-05 Upgrade Raymond James Underperform to Market Perform
2016-01-05 Upgrade Raymond James Financial Inc. Underperform to Market Perform
2015-11-24 Reiterated Rating Roth Capital Buy $6.25 to $5.00
2015-10-02 Reiterated Rating Roth Capital Buy $7.00 to $6.25
2015-10-02 Reiterated Rating Dundee Securities Buy $9.20 to $8.50
2015-07-21 Lower Price Target Citigroup Inc. Neutral $8.85 to $6.00
2015-06-29 Reiterated Rating HC Wainwright Buy $6.30
2015-05-14 Reiterated Rating HC Wainwright Buy $11.00 to $10.00
2015-05-12 Reiterated Rating Citigroup Inc. Neutral $5.05 to $8.85
2015-03-02 Reiterated Rating Raymond James Underperform
2015-02-27 Boost Price Target Citigroup Inc. Neutral $4.80 to $5.05
2015-01-20 Lower Price Target Citigroup Inc. Neutral $7.50 to $4.80
2015-01-05 Set Price Target MLV & Co. Hold $7.00
2014-12-08 Downgrade Ascendiant Capital Markets Buy to Hold
2014-10-24 Reiterated Rating Piper Jaffray Underweight
2014-10-24 Lower Price Target Northland Securities Market Perform $10.00 to $6.00
2014-10-24 Reiterated Rating Piper Jaffray Cos. Underweight
2014-10-17 Initiated Coverage MLV & Co. Hold $8.00
2014-05-29 Initiated Coverage Morgan Stanley Buy to Overweight $14.00
2014-02-28 Downgrade Dougherty & Co Buy to Neutral
2014-02-12 Downgrade Macquarie Neutral to Underperform
2014-01-06 Initiated Coverage Citigroup Inc. Neutral $13.00
2013-10-08 Reiterated Rating Piper Jaffray Sell $9.50 to $4.50
2013-03-11 Initiated Ascendiant Capital Markets Buy $15.50
2012-06-28 Initiated Capstone Investments Buy $18
2012-06-06 Upgrade Northland Securities Market Perform to Outperform $20 to $20
2011-07-12 Upgrade Northland Securities Market Perform to Outperform
2010-03-11 Upgrade Northland Securities Market Perform to Outperform $17.50 to $25
2010-01-08 Downgrade Northland Securities Outperform to Market Perform $17.50
2009-12-08 Initiated Raymond James Outperform
2009-07-06 Reiterated Lazard Capital Mkts Buy $10 to $12
2009-05-01 Initiated ThinkEquity Buy $11
2009-04-07 Reiterated Northland Securities Outperform $7 to $8.50
2016-03-14 Boost Price Target Jefferies Group Hold $4.00 to $6.00
2016-01-05 Upgrade Raymond James Underperform to Market Perform
2016-01-05 Upgrade Raymond James Financial Inc. Underperform to Market Perform
2015-11-24 Reiterated Rating Roth Capital Buy $6.25 to $5.00
2015-10-02 Reiterated Rating Roth Capital Buy $7.00 to $6.25

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
PICKENS BOONE 14.53%  (13060978) CLNE / XCO /
Littlefair Andrew J CEO and President 1.75%  (1574049) CLNE / HTH /
Pratt Mitchell W COO and Secretary 0.75%  (676249) CLNE /
Corbus Barclay SVP, Strategic Development 0.58%  (524113) CLNE /
Herrington John S 0.45%  (404609) CLNE /
Harger James N Chief Marketing Officer 0.42%  (376928) CLNE /
Wheeler Richard R Chief Financial Officer 0.33%  (294209) CLNE /
Vreeland Robert M. Chief Financial Officer 0.32%  (289404) CLNE /
Mitchell Warren I 0.21%  (189218) CLNE /
Taormina Vincent C 0.21%  (187018) CLNE /
SOCHA KENNETH M 0.21%  (184728) CLNE /
Scully Stephen 0.20%  (179118) CLNE /
MILLER JAMES C III 0.14%  (130001) CLNE /
OCONNOR JAMES E 0.14%  (127118) CLNE / CWST / SWSH /

Comments